Guangzhou Wondfo Biotech Co Ltd Strategic Asset Allocation Index
Guangzhou Wondfo Biotech Co Ltd strategic asset allocation index. Guangzhou Wondfo Biotech Co Ltd (300482) has a Strategic Asset Allocation Index of 26.2% as of December 2022. Strategic assets (PP&E of CN¥1.19 Billion plus long-term investments of CN¥-) total CN¥1.19 Billion, measured against net assets of CN¥4.54 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible net worth ratio of Guangzhou Wondfo Biotech Co Ltd to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Guangzhou Wondfo Biotech Co Ltd (2011–2022)
Strategic asset allocation index of Guangzhou Wondfo Biotech Co Ltd from 2011 to 2022. This chart shows how Guangzhou Wondfo Biotech Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of December 2022, the index stands at 26.2%, representing strategic assets of CN¥1.19 Billion against net assets of CN¥4.54 Billion CNY.
Guangzhou Wondfo Biotech Co Ltd Strategic Asset Allocation Index by Year (2011–2022)
Guangzhou Wondfo Biotech Co Ltd strategic asset allocation index by year from 2011 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Guangzhou Wondfo Biotech Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Guangzhou Wondfo Biotech Co Ltd (300482) market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 26.2% | CN¥1.19 Billion | CN¥1.19 Billion | CN¥- | CN¥4.54 Billion | ▲ +0.4 pp |
| 2021 | 25.9% | CN¥906.09 Million | CN¥906.09 Million | CN¥- | CN¥3.50 Billion | ▲ +3.3 pp |
| 2020 | 22.6% | CN¥676.63 Million | CN¥676.63 Million | CN¥- | CN¥2.99 Billion | ▲ +2.0 pp |
| 2019 | 20.6% | CN¥505.86 Million | CN¥505.86 Million | CN¥- | CN¥2.46 Billion | ▼ -6.6 pp |
| 2018 | 27.2% | CN¥584.50 Million | CN¥396.68 Million | CN¥187.82 Million | CN¥2.15 Billion | ▼ -5.0 pp |
| 2017 | 32.1% | CN¥382.54 Million | CN¥254.12 Million | CN¥128.41 Million | CN¥1.19 Billion | ▲ +5.2 pp |
| 2016 | 26.9% | CN¥230.01 Million | CN¥223.77 Million | CN¥6.24 Million | CN¥854.75 Million | ▼ -2.4 pp |
| 2015 | 29.3% | CN¥205.08 Million | CN¥151.18 Million | CN¥53.90 Million | CN¥700.64 Million | ▼ -17.5 pp |
| 2014 | 46.7% | CN¥146.49 Million | CN¥146.49 Million | CN¥- | CN¥313.43 Million | ▼ -9.8 pp |
| 2013 | 56.5% | CN¥136.44 Million | CN¥136.44 Million | CN¥- | CN¥241.47 Million | ▼ -13.4 pp |
| 2012 | 69.9% | CN¥127.52 Million | CN¥127.52 Million | CN¥- | CN¥182.48 Million | ▼ -6.5 pp |
| 2011 | 76.4% | CN¥110.48 Million | CN¥110.48 Million | CN¥- | CN¥144.61 Million | — |